NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/14/2024
Back to search
Official data from USPTO
CITAGENIX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
64
Latest update
05/14/2024
Trademark type
Combined
Nice classes
35, 41
Filing date
01/30/2019
Registration date
05/14/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/14/2024
Last transaction
05/14/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
5
Owner type
03
Owner location
Quebec, CA
Examiner
BULLOFF, TOBY ELLEN
Law office
N10
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the word "CITAGENIX" with a stylized "N".
Holders and representatives
Holders
Citagenix Inc.
Representatives
Rebecca Liebowitz Venable LLP
Technical classification
Nice Classes
Class 35Class 41
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Distributorship services and wholesale ordering services of membranes for medical usebone graft material for bone graftingdentalorthopedic and veterinary applications; distributorship services and wholesale ordering services of medical devices destined to professionals in the field of bone regenerationbone graftingdentistryveterinary science and orthopedics; online retail store services featuring membranes for medical usebone graft material for bone graftingdentalorthopedic and veterinary applications; online retail store services featuring medical devices destined to professionals in the field of bone regenerationbone graftingdentistryveterinary science and orthopedics; developing marketing strategies for others of bone regeneration products for professionals in the field of bone graftingdentistryveterinary science and orthopedics; developing marketing strategies for others of medical devices destined to professionals in the field of bone regenerationbone graftingdentistryveterinary science and orthopedics
Class 41
Providing educational servicesclassesseminarsworkshops and training services in the field of bone regenerationbone graftingdentistryveterinary science and orthopedics; arranging and conducting classesseminars and workshops in the field of bone regenerationbone graftingdentistryveterinary science and orthopedics
Publications
History of USPTO decisions and trademark events.
64 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/14/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/04/2024
PUBO
PUBLISHED FOR OPPOSITION
02/27/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/07/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/07/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/23/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/22/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/22/2024
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
01/18/2024
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
10/25/2023
GNSL
LETTER OF SUSPENSION E-MAILED
10/25/2023
CNSL
SUSPENSION LETTER WRITTEN
10/25/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/24/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/24/2023
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
10/24/2023
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
08/03/2023
GNSI
INQUIRY TO SUSPENSION E-MAILED
08/03/2023
CNSI
SUSPENSION INQUIRY WRITTEN
08/03/2023
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
01/31/2023
GNSL
LETTER OF SUSPENSION E-MAILED
01/31/2023
CNSL
SUSPENSION LETTER WRITTEN
01/31/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/30/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/30/2023
ALIE
ASSIGNED TO LIE
01/30/2023
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
01/23/2023
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
08/01/2022
GNSI
INQUIRY TO SUSPENSION E-MAILED
08/01/2022
CNSI
SUSPENSION INQUIRY WRITTEN
08/01/2022
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
02/01/2022
GNSL
LETTER OF SUSPENSION E-MAILED
02/01/2022
CNSL
SUSPENSION LETTER WRITTEN
02/01/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/01/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/01/2022
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
01/25/2022
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
08/02/2021
GNSI
INQUIRY TO SUSPENSION E-MAILED
08/02/2021
CNSI
SUSPENSION INQUIRY WRITTEN
08/02/2021
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
07/22/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
09/23/2020
GNSL
LETTER OF SUSPENSION E-MAILED
09/23/2020
CNSL
SUSPENSION LETTER WRITTEN
09/23/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/23/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/23/2020
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
09/17/2020
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
04/06/2020
GNSI
INQUIRY TO SUSPENSION E-MAILED
04/06/2020
CNSI
SUSPENSION INQUIRY WRITTEN
04/06/2020
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
04/01/2020
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
10/01/2019
GNSL
LETTER OF SUSPENSION E-MAILED
10/01/2019
CNSL
SUSPENSION LETTER WRITTEN
10/01/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/26/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/25/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/25/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/11/2019
GNRT
NON-FINAL ACTION E-MAILED
04/11/2019
CNRT
NON-FINAL ACTION WRITTEN
04/11/2019
DOCK
ASSIGNED TO EXAMINER
04/11/2019
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
03/16/2019
ALIE
ASSIGNED TO LIE
03/16/2019
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
03/12/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/22/2019
NWAP
NEW APPLICATION ENTERED
02/02/2019
Continuous trademark protection
Get notified about every new filing that threatens CITAGENIX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.